1887

oa SA Pharmaceutical Journal - Pfizer : press release

Volume 78, Issue 4
  • ISSN : 2221-5875

 

Abstract

Pfizer Laboratories (PTY) LTD is proud to announce the launch of Champix® (varencline tartrate), a nicotine receptor partial agonist for smoking cessation.

Loading full text...

Full text loading...

Loading

Article metrics loading...

/content/mp_sapj/78/4/EJC82569
2011-05-01
2016-12-11

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error